Protara Therapeutics, Inc. (TARA) Misses Q1 EPS by 6c

Protara Therapeutics, Inc. (NASDAQ: TARA) reported Q1 EPS of ($0.97), $0.06 worse than the analyst estimate of ($0.91).

For earnings history and earnings-related data on Protara Therapeutics, Inc. (TARA) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Yum! Brands (YUM) PT Lowered to $180 at Argus
• The LGL Group (LGL) Misses Q2 EPS by 8c